Nov 25, 2008 - Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with AstraZeneca to settle patent litigation involving Teva's U.S. generic version of AstraZeneca's Pulmicort (Budesonide) Respules including all claims for patent infringement and damages.
The details can be read here.
Other related links:
Businesswire....
Yahoo...
No comments:
Post a Comment